[Eradication of Helicobacter pylori in patients with end-stage renal disease undergoing dialysis treatment].
作者信息
Tsukada Katsuhiko, Katoh Hiroyuki, Miyazaki Tatsuya, Kuwano Hiroyuki
机构信息
Department of General Surgical Science, Gunma University, Graduate School of Medicine.
出版信息
Nihon Rinsho. 2005 Nov;63 Suppl 11:486-8.
PMID:16363585
Abstract
摘要
相似文献
1
[Eradication of Helicobacter pylori in patients with end-stage renal disease undergoing dialysis treatment].
Nihon Rinsho. 2005 Nov;63 Suppl 11:486-8.
2
[Helicobacter pylori eradication therapy for children].
Nihon Rinsho. 2005 Nov;63 Suppl 11:470-3.
3
[Eradication therapy for clarithromycin-resistant and metronidazole-resistant Helicobacter pylori infection].
Nihon Rinsho. 2002 Feb;60 Suppl 2:460-4.
4
[Adverse effects of Helicobacter pylori eradication and its prevention].
Nihon Rinsho. 2005 Nov;63 Suppl 11:414-7.
5
[Guidelines in the management of H. pylori infection in Japan].
Nihon Rinsho. 2005 Nov;63 Suppl 11:12-6.
6
[Triple therapy for eradication of Helicobacter pylori in Japan].
Nihon Rinsho. 2005 Nov;63 Suppl 11:409-13.
7
[Comparison between one-week and two-week regimens of new triple therapy in H. pylori eradication].
Nihon Rinsho. 2005 Nov;63 Suppl 11:459-60.
8
[Is antimicrobial susceptibility testing necessary before second-line treatment for Helicobacter pylori infection?].
Nihon Rinsho. 2005 Nov;63 Suppl 11:421-5.
9
[Triple therapy with faropenem, proton pump inhibitor (PPI), and amoxicillin for clarithromycin-resistant H. pylori eradication].
Nihon Rinsho. 2002 Feb;60 Suppl 2:452-4.
10
[Cetraxate hydrochloride (Neuer) induces the effectiveness of new triple therapy in H. pylori eradication].
Nihon Rinsho. 2005 Nov;63 Suppl 11:461-4.
Zotero 插件